Correlation Between NewAmsterdam Pharma and Qualigen Therapeutics
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Qualigen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Qualigen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Qualigen Therapeutics, you can compare the effects of market volatilities on NewAmsterdam Pharma and Qualigen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Qualigen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Qualigen Therapeutics.
Diversification Opportunities for NewAmsterdam Pharma and Qualigen Therapeutics
-0.8 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between NewAmsterdam and Qualigen is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Qualigen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qualigen Therapeutics and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Qualigen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qualigen Therapeutics has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Qualigen Therapeutics go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and Qualigen Therapeutics
Given the investment horizon of 90 days NewAmsterdam Pharma is expected to generate 0.87 times more return on investment than Qualigen Therapeutics. However, NewAmsterdam Pharma is 1.15 times less risky than Qualigen Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Qualigen Therapeutics is currently generating about -0.13 per unit of risk. If you would invest 1,913 in NewAmsterdam Pharma on August 29, 2024 and sell it today you would earn a total of 171.00 from holding NewAmsterdam Pharma or generate 8.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NewAmsterdam Pharma vs. Qualigen Therapeutics
Performance |
| Timeline |
| NewAmsterdam Pharma |
| Qualigen Therapeutics |
NewAmsterdam Pharma and Qualigen Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NewAmsterdam Pharma and Qualigen Therapeutics
The main advantage of trading using opposite NewAmsterdam Pharma and Qualigen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Qualigen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qualigen Therapeutics will offset losses from the drop in Qualigen Therapeutics' long position.| NewAmsterdam Pharma vs. Bright Minds Biosciences | NewAmsterdam Pharma vs. HP Inc | NewAmsterdam Pharma vs. Intel | NewAmsterdam Pharma vs. Chevron Corp |
| Qualigen Therapeutics vs. ZyVersa Therapeutics | Qualigen Therapeutics vs. Immix Biopharma | Qualigen Therapeutics vs. Phio Pharmaceuticals Corp | Qualigen Therapeutics vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |